Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc.verified

CGTX

Price:

$0.4709

Market Cap:

$18.90M

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for...[Read more]

Industry

Biotechnology

IPO Date

2021-10-08

Stock Exchange

NASDAQ

Ticker

CGTX

The Dividend Yield as of November 2024 (TTM) for Cognition Therapeutics, Inc. (CGTX) is 0%

According to Cognition Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Cognition Therapeutics, Inc. (CGTX) Historical Dividend Yield (quarterly & annually)

How has CGTX Dividend Yield performed in the past?

The mean historical Dividend Yield of Cognition Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), CGTX's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Cognition Therapeutics, Inc. (CGTX) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Cognition Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%

Cognition Therapeutics, Inc. (CGTX) Average Dividend Yield

How has CGTX Dividend Yield performed in the past?

The current Dividend Yield of Cognition Therapeutics, Inc. (CGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Cognition Therapeutics, Inc. (CGTX) Dividend Yield vs. Peers

How is CGTX’s Dividend Yield compared to its peers?

Cognition Therapeutics, Inc.’s Dividend Yield is less than Reviva Pharmaceuticals Holdings, Inc. (0%), less than Eyenovia, Inc. (0%), less than TransCode Therapeutics, Inc. (0%), less than Kodiak Sciences Inc. (0%), less than TFF Pharmaceuticals, Inc. (0%), less than TScan Therapeutics, Inc. (0%), less than Cue Biopharma, Inc. (0%), less than Dermata Therapeutics, Inc. (0%), less than Gain Therapeutics, Inc. (0%), less than aTyr Pharma, Inc. (0%), less than IN8bio, Inc. (0%), less than Lantern Pharma Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Bolt Biotherapeutics, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Autolus Therapeutics plc (0%), less than null (0%),

Build a custom stock screener for Cognition Therapeutics, Inc. (CGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cognition Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cognition Therapeutics, Inc. (CGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cognition Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Cognition Therapeutics, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Cognition Therapeutics, Inc. (CGTX)?

What is the highest Dividend Yield for Cognition Therapeutics, Inc. (CGTX)?

What is the 3-year average Dividend Yield for Cognition Therapeutics, Inc. (CGTX)?

What is the 5-year average Dividend Yield for Cognition Therapeutics, Inc. (CGTX)?

How does the current Dividend Yield for Cognition Therapeutics, Inc. (CGTX) compare to its historical average?